NCT04164979 2025-08-11Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal AdenocarcinomaUniversity of California, IrvinePhase 2 Active not recruiting34 enrolled 11 charts